ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021

Cost-effectiveness of bezlotoxumab and fidaxomicin for initial Clostridioides difficile infection.

Jiahe Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.